ESMO 2024: Treatment of uHCC - Episode 7

LEAP-012 Study Results

, , , , ,

Panelists discuss the results of the LEAP-012 study, highlighting the efficacy of transarterial chemoembolization combined with lenvatinib and pembrolizumab in patients with intermediate-stage hepatocellular carcinoma and Child-Pugh class A disease.

Video content above is prompted by the following:

Dr Li: Please discuss the findings from the LEAP-012 study in patients with Child-Pugh class A disease.